Bristol-Myers Squibb Company (BMY)
NYSE · Healthcare
Bristol-Myers Squibb Company Net Income 2007–2025
Bristol-Myers Squibb Company annual/quarterly net income history and growth rate from 2007 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Bristol-Myers Squibb Company net income for the quarter ending March 31, 2026 was 2.7 B, a 9.00% increase year-over-year.
- Bristol-Myers Squibb Company net income for the twelve months ending March 31, 2026 was 8.6 B, a 221.88% decrease year-over-year.
- Bristol-Myers Squibb Company annual net income for 2025 was 7.1 B, a 178.83% decrease from 2024.
- Bristol-Myers Squibb Company annual net income for 2024 was -8.9 B, a 211.50% decrease from 2023.
- Bristol-Myers Squibb Company annual net income for 2023 was 8.0 B, a 26.84% increase from 2022.
- Bristol-Myers Squibb Company annual net income for 2022 was 6.3 B.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Bristol-Myers Squibb Company Net Income — FAQ
Bristol-Myers Squibb Company (BMY) net income over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
What is Bristol-Myers Squibb Company's net income?
Bristol-Myers Squibb Company (BMY) reported net income of $7.05B for fiscal 2025.
Where can I see BMY's net income history?
The chart and table above show Bristol-Myers Squibb Company's net income by year and by quarter, including the growth rate.